ArticleHealth science reports2026
Utility of the Triglyceride and HDL Cholesterol Index in Older Persons in Colombia.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Alterations in lipid metabolism are key contributors to the development of atherogenesis and the increasing prevalence of atherosclerotic cardiovascular diseases, including coronary artery disease, peripheral arterial disease, and cerebrovascular disease. The triglyceride-to-HDL cholesterol (TG/HDL-c) index is commonly used to assess cardiovascular disease risk; however, its effectiveness in older adults remains unclear. Methods: This study evaluated the association and predictive capacity of the TG/HDL-c index for cardiometabolic risk factors in older adults from the SABE Colombian study. A cross-sectional analysis was performed among adults aged ≥ 60 years from the national SABE survey. Univariable and multivariable logistic regression models were constructed to examine associations between the TG/HDL-c index and diabetes or metabolic syndrome, adjusting for age, sex, BMI, smoking, diet, and physical activity. Discriminatory capacity was assessed using receiver operating characteristic curves, and optimal cut-off points were determined using the Youden index. Results: A total of 23,694 participants with a median age of 69 years were included; 57.3% were women. The TG/HDL-c index was independently associated with both diabetes (adjusted OR per 1 SD: 1.25; 95% CI: 1.13-1.37; Conclusions: The TG/HDL-c index was independently associated with diabetes and metabolic syndrome and demonstrated good discriminatory performance in this nationally representative sample of older adults. Although these results highlight its potential utility for identifying individuals at higher cardiometabolic risk, further longitudinal studies are needed to validate these findings and determine the prognostic value of TG/HDL-c for clinical decision-making in elderly populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.